Please wait. Loading...
 
Latest News
Found 0 results. Page 1 of 0

URINARY SYSTEM  

BENIGN PROSTATIC ΗYPERPLASIA

 
 

HYΤRΙΝ TAB 2 MG/TAB and 5 MG/TAB

ΒΤΧ14 tab


 Terazocin  2mg and  5mg per tablet

AMDIPHARM (U.K.)

Use in benign Prostatic Hyperplasia:

Studies suggest that alpha-1-adrenoreceptor antagonism is useful in improving the urodynamics in patients with chronic obstruction such as in benign prostatic hyperplasia (BPH).

Use in hypertension:

Although the exact mechanism of the hypotensive action is not established, the relaxation of peripheral blood vessels appears to be produced mainly by competitive antagonism of post-synaptic alpha-1-adrenoceptor. Terazosin usually produces an initial gradual decrease in blood pressure followed by a sustained anti hypertensive action.



  • Indications 

Terazosin tablets are indicated for:

• the treatment of mild to moderate hypertension

• symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia (BPH).                                                                                     

Posology:

For oral use.

For the different dosage regimens suitable strengths are available.

The dose of terazosin should be adjusted according to the patient's response.



Πηγή: www.galinos.gr

Contact

ATHENSTHESSALONIKI

Phone:
+30210 2014306

FAX:
+30210 2014323

Email: info@kite.gr

Phone & Fax:
+302310 457786

Newsletter

Subscribe to our Newsletter

  •  
Developed by LogicONE Logo LogicONE